Published in Cardiologia on December 01, 1995
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47
Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation (2000) 5.09
Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation (1995) 4.48
Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med (1998) 3.41
Proposed diagnostic criteria for the Brugada syndrome. Eur Heart J (2002) 3.01
Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation (2000) 2.95
Exercise training confers anticipatory protection from sudden death during acute myocardial ischemia. Circulation (1994) 2.79
Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation (1998) 2.53
Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. Hum Mol Genet (1995) 2.30
A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proc Natl Acad Sci U S A (2000) 2.26
Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome. Eur Heart J (2002) 2.17
Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation (1992) 2.09
A molecular link between the sudden infant death syndrome and the long-QT syndrome. N Engl J Med (2000) 2.02
Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation (1988) 1.99
Inherited Brugada and long QT-3 syndrome mutations of a single residue of the cardiac sodium channel confer distinct channel and clinical phenotypes. J Biol Chem (2001) 1.78
Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias. J Cardiovasc Electrophysiol (2000) 1.74
Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel. Circ Res (2001) 1.72
Electrocardiographic prediction of abnormal genotype in congenital long QT syndrome: experience in 101 related family members. J Cardiovasc Electrophysiol (2001) 1.71
Molecular diagnosis in a child with sudden infant death syndrome. Lancet (2001) 1.66
Gene-specific differences in the circadian variation of ventricular repolarization in the long QT syndrome: a key to sudden death during sleep? Ital Heart J (2000) 1.59
New mutations in the KVLQT1 potassium channel that cause long-QT syndrome. Circulation (1998) 1.53
Do increases in markers of vagal activity imply protection from sudden death? The case of scopolamine. Circulation (1995) 1.48
Inferior vena cava loop of the implantable cardioverter defibrillator endocardial lead: a possible solution of the growth problem in pediatric implantation. Pacing Clin Electrophysiol (2000) 1.48
Cellular dysfunction of LQT5-minK mutants: abnormalities of IKs, IKr and trafficking in long QT syndrome. Hum Mol Genet (1999) 1.43
Unexpected interaction between beta-adrenergic blockade and heart rate variability before and after myocardial infarction. A longitudinal study in dogs at high and low risk for sudden death. Circulation (1994) 1.41
Brugada syndrome and sudden cardiac death in children. Lancet (2000) 1.40
Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol (1999) 1.25
Mechanisms of I(Ks) suppression in LQT1 mutants. Am J Physiol Heart Circ Physiol (2000) 1.24
Protective effect of vagal stimulation on reperfusion arrhythmias in cats. Circ Res (1987) 1.20
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction. J Am Coll Cardiol (1993) 1.18
Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in LQT1 than LQT2 forms of congenital long QT syndrome. J Am Coll Cardiol (2001) 1.12
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia. Cell Death Dis (2013) 1.01
Torsade de pointes. Mechanisms and management. Drugs (1994) 1.01
Heart rate variability before and after myocardial infarction in conscious dogs at high and low risk of sudden death. J Am Coll Cardiol (1990) 1.00
Novel characteristics of a misprocessed mutant HERG channel linked to hereditary long QT syndrome. Am J Physiol Heart Circ Physiol (2000) 1.00
Vagal reflexes and survival during acute myocardial ischemia in conscious dogs with healed myocardial infarction. Am J Physiol (1991) 0.93
Sympathetic-parasympathetic interaction and accentuated antagonism in conscious dogs. Am J Physiol (1991) 0.87
The effect of antiarrhythmic drugs on life-threatening arrhythmias induced by the interaction between acute myocardial ischemia and sympathetic hyperactivity. Am Heart J (1985) 0.87
Five-minute recording of heart rate variability in severe chronic heart failure: correlates with right ventricular function and prognostic implications. Am Heart J (2000) 0.86
Exploring the hidden danger of noncardiac drugs. J Cardiovasc Electrophysiol (1998) 0.85
Prevention of life-threatening arrhythmias by pharmacologic stimulation of the muscarinic receptors with oxotremorine. Am Heart J (1992) 0.84
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents. J Am Coll Cardiol (1995) 0.83
Pertussis toxin-induced ADP ribosylation of inhibitor G proteins alters vagal control of heart rate in vivo. Am J Physiol (1993) 0.81
Muscarinic effects on action potential duration and its rate dependence in canine Purkinje fibers. Pacing Clin Electrophysiol (1996) 0.81
Homozygous deletion in KVLQT1 associated with Jervell and Lange-Nielsen syndrome. Circulation (1999) 0.80
Clinical profile and genetic basis of Brugada syndrome in the Chinese population. Hong Kong Med J (2004) 0.80
Cardiac arrhythmias elicited by interaction between acute myocardial ischemia and sympathetic hyperactivity: a new experimental model for the study of antiarrhythmic drugs. J Cardiovasc Pharmacol (1982) 0.80
Lack of correlation between occlusion and reperfusion arrhythmias in the cat. Am Heart J (1985) 0.79
Early autonomic and repolarization abnormalities contribute to lethal arrhythmias in chronic ischemic heart failure: characteristics of a novel heart failure model in dogs with postmyocardial infarction left ventricular dysfunction. J Am Coll Cardiol (2001) 0.79
Response of cytochrome a,a3 to carbon monoxide in canine hearts with prior infarcts. Life Sci (1988) 0.78
Brugada syndrome and sudden death. Eur Heart J (2000) 0.78
Adrenergic effects on force-frequency relationship: a pivotal role for the cardiac intrinsic systems. Acta Physiol (Oxf) (2011) 0.78
[Long QT syndrome and Brugada syndrome: 2 aspects of the same disease?]. Ital Heart J Suppl (2001) 0.77
Predictors of medical events and of their competitive interactions in the Cardiac Insufficiency Bisoprolol Study 2 (CIBIS-2). Am Heart J (2001) 0.77
Efficacy of diltiazem in two experimental feline models of sudden cardiac death. J Am Coll Cardiol (1986) 0.76
Cardiovascular safety of second-generation antihistamines. Am J Rhinol (1999) 0.76
Antifibrillatory efficacy of ersentilide, a novel beta-adrenergic and Ikr blocker, in conscious dogs with a healed myocardial infarction. Cardiovasc Res (1998) 0.76
From catheters to vectors: the dawn of molecular electrophysiology. Nat Med (2000) 0.76
Foretelling the future in Brugada syndrome: do we have the crystal ball? J Cardiovasc Electrophysiol (2001) 0.76
Is long QT syndrome entering the era of molecular diagnosis? Heart (1997) 0.75
An experimental approach to the choice of antiarrhythmic therapy. Eur Heart J (1986) 0.75
T wave alternans detection during exercise stress test and during dobutamine stress. A comparative study in patients with a recent myocardial infarction. Ital Heart J (2001) 0.75
[Genetic basis of sudden cardiac death]. Recenti Prog Med (2000) 0.75
[Baroceptive reflex sensibility in non-anesthetized animals. Evaluation and comparison of 2 methods applicable to humans]. Cardiologia (1988) 0.75
Delineation of the influence of propionylcarnitine on the accumulation of long-chain acylcarnitines and electrophysiologic derangements evoked by hypoxia in canine myocardium. Cardiovasc Drugs Ther (1991) 0.75
Experimental evaluation of antiarrhythmic drugs efficacy. Cardiologia (1983) 0.75
[Physiopathology of the autonomic nervous system activity during sleep]. Ital Heart J Suppl (2001) 0.75
[A new experimental model for the study of arrhythmias dependent on the interaction between myocardial ischemia and sympathetic hyperactivity. I. Effects of phosphocreatinine]. Boll Soc Ital Cardiol (1978) 0.75
Influence of residual ischaemia on heart rate variability after myocardial infarction. Eur Heart J (1997) 0.75
Baroreceptor reflexes and sudden cardiac death: experimental findings and background. G Ital Cardiol (1992) 0.75
Multiple comparison of several antiarrhythmic agents by acute oral drug testing in patients with chronic ventricular arrhythmias. Eur Heart J (1988) 0.75
8B.02: EFFECTS OF LONG-TERM BAROREFLEX ACTIVATION IN CONGESTIVE HEART FAILURE. J Hypertens (2015) 0.75
[Effects of vagal stimulation in conscious dogs with previous myocardial infarct]. Cardiologia (1988) 0.75
Significance of QT dispersion in the long QT syndrome. Prog Cardiovasc Dis (2000) 0.75
Left cardiac sympathetic denervation in long QT syndrome patients. J Interv Cardiol (1995) 0.75
Efficacy and safety of flecainide in low-risk patients with chronic ventricular arrhythmias: a two-year follow-up. Am Heart J (1989) 0.75
Carbon monoxide and lethal arrhythmias. Res Rep Health Eff Inst (1990) 0.75